Eman El-Beltagi | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Best Researcher Award

Eman El-Beltagi
Affiliation Tanta University
Country Egypt
Scopus ID 58139936100
Documents 6
Citations 11
h-index 2
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
Google Scholar ID q2Zv1jIAAAAJ

Eman El-Beltagi

Tanta University, Egypt

Eman El-Beltagi is an academic researcher affiliated with Tanta University whose scholarly activities primarily focus on histology, experimental pathology, neuroscience, regenerative medicine, and microscopic anatomy. Her published studies investigate disease mechanisms, tissue alterations, and potential therapeutic interventions using experimental animal models. The recognition under the International Forensic Scientist Awards acknowledges sustained scholarly contribution, publication quality, and developing research influence within biomedical sciences.[1]

Abstract

This article summarizes the academic profile of Eman El-Beltagi in relation to recognition for the Best Researcher Award. Her research portfolio demonstrates continuing interest in histological evaluation, immunohistochemistry, neurodegenerative disease models, stem cell therapy, reproductive biology, and experimental toxicology. Published studies emphasize careful microscopic analysis and laboratory-based investigations that contribute to understanding pathological mechanisms and potential therapeutic strategies. According to the available publication metrics, the researcher has produced six indexed documents with eleven citations and an h-index of two, reflecting an emerging scholarly record within medicine and health sciences.[2]

Keywords

Histology; Immunohistochemistry; Experimental Medicine; Neuroscience; Stem Cell Therapy; Toxicology; Microscopy; Biomedical Research.

Introduction

Modern biomedical science relies upon detailed morphological and experimental investigations to improve understanding of disease progression and therapeutic response. Researchers working in histology and pathology provide foundational evidence supporting translational medicine. Eman El-Beltagi has participated in studies examining neurological disorders, reproductive health, endocrine development, and tissue regeneration through microscopic and immunohistochemical methodologies.[3]

Research Profile

The research profile encompasses laboratory investigations published in peer-reviewed biomedical journals. Indexed publications address Alzheimer’s disease models, protective effects of natural compounds, reproductive toxicology, adrenal gland development, and tissue pathology. The research combines histological examination with immunohistochemistry to evaluate structural and functional biological changes.[1]

Research Contributions

  • Investigated geraniol-mediated neuroprotection against experimentally induced memory impairment.
  • Evaluated histological changes associated with gibberellic acid exposure in experimental models.
  • Contributed to studies on mesenchymal stem cell therapy for neurodegenerative disease.
  • Published recent investigations on adrenal gland development and microscopic anatomy.

Publications

  • Mechanistic Insights into Ameliorating Effect of Geraniol on d-Galactose Induced Memory Impairment in Rats (2022).
  • Histological and Immunohistochemical Study on the Effect of Gibberellic Acid on Seminiferous Tubules (2017).
  • Post-hatch Development of the Adrenal Gland in Chickens (2025).
  • Bone Marrow-Derived Mesenchymal Stem Cells in Alzheimer’s Disease Model (2022).
  • Histological Study of Sofosbuvir Effects on Salivary Glands and Tongue (2025).

Research Impact

Available citation indicators demonstrate measurable scholarly engagement with the published work. Although the publication portfolio remains relatively concise, the studies address clinically relevant topics including neurodegeneration, toxicology, and regenerative medicine. Continued publication activity and interdisciplinary collaboration may further strengthen academic visibility and citation performance over time.[2]

Award Suitability

The documented research activities demonstrate consistent participation in biomedical investigations supported by peer-reviewed publications. Contributions to experimental medicine, histology, and disease-model research align with the objectives of academic recognition programs that evaluate scientific productivity, research quality, and contribution to knowledge advancement. Selection decisions remain subject to the independent evaluation criteria established by the awarding organization.[5]

Conclusion

Eman El-Beltagi has developed a focused research profile centered on histopathology, immunohistochemistry, and experimental biomedical science. Her publications contribute to understanding disease mechanisms and potential therapeutic approaches while supporting continued scientific development within medicine and health sciences. The available scholarly metrics and research outputs provide an evidence-based overview suitable for academic recognition documentation.

References

  1. Elsevier. (n.d.). Scopus author details: Eman El-Beltagi, Author ID 58139936100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58139936100
  2. Atef MM, et al. (2022). Mechanistic Insights into Ameliorating Effect of Geraniol on d-Galactose Induced Memory Impairment in Rats.
    https://doi.org/10.1007/s11064-022-03598-6
  3. Tanta Medical Journal. (2017). Histological and Immunohistochemical Study on the Effect of Gibberellic Acid.
  4. Microscopy and Microanalysis. (2025). Post-hatch Development of the Adrenal Gland in Chickens.
  5. International Forensic Scientist Awards. Official Award Information.
    forensicscientist.org

Mohammad El Garhy | Medicine and Health Sciences | Best Innovation Award

Published on by Forensic Scientist Awards

Best Innovation Award

Mohammad El Garhy
Researcher Mohammad El Garhy
Affiliation Department of Internal Medicine I, Cardiology, University Hospital Jena
Country Germany
Scopus ID 57192109926
Documents 19
Citations 219
h-index 5
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-8578-0135

Mohammad El Garhy
Department of Internal Medicine I, Cardiology, University Hospital Jena, Germany

The Best Innovation Award recognizes scholarly contributions demonstrating scientific originality, translational relevance, and measurable impact within their respective disciplines. Mohammad El Garhy is a cardiology researcher whose academic work emphasizes structural heart disease, transcatheter cardiovascular interventions, multimodality imaging, and minimally invasive diagnostic technologies. His publications reflect continued participation in collaborative clinical research concerning transcatheter valve therapies, cardiovascular imaging, and interventional cardiology, contributing to evidence-based improvements in patient management.[1]

Abstract

Mohammad El Garhy has developed a publication record focused on interventional cardiology, cardiovascular imaging, and catheter-based structural heart interventions. His research addresses clinically important topics including transcatheter aortic valve implantation, MitraClip therapy, computed tomography-based valve assessment, and the expanding role of endoscopic ultrasound in cardiovascular diagnosis. These investigations contribute to improved procedural planning and patient outcomes while supporting innovation in minimally invasive cardiovascular medicine.[2]

Keywords

  • Interventional Cardiology
  • Transcatheter Valve Therapy
  • Cardiovascular Imaging
  • Structural Heart Disease
  • Medical Innovation

Introduction

Advances in structural heart interventions increasingly depend upon precise imaging, multidisciplinary clinical decision-making, and minimally invasive therapeutic strategies. Mohammad El Garhy’s scholarly work aligns with these developments by examining diagnostic technologies and transcatheter procedures that support evidence-based cardiovascular care. His publications have appeared in peer-reviewed journals dedicated to clinical cardiology and cardiovascular interventions.[3]

Research Profile

According to the supplied academic metrics, Mohammad El Garhy has authored 19 indexed publications with 219 citations and an h-index of 5. His primary research interests include transcatheter aortic valve implantation, mitral valve repair, computed tomography assessment of valvular disease, endoscopic ultrasound applications, and cardiovascular intervention planning.[1]

Research Contributions

  • Evaluation of transcatheter mitral valve repair outcomes.
  • Clinical assessment of porcelain aorta during TAVI procedures.
  • Studies comparing CT-based aortic valve calcium quantification methods.
  • Investigation of endoscopic ultrasound for cardiovascular diagnosis and intervention.
  • Clinical analyses supporting minimally invasive structural heart therapies.

Publications

  • The Role of Endoscopic Ultrasound in Cardiology (2026).
  • Impact of Porcelain Aorta on Outcomes in TAVI (2025).
  • Transcatheter Mitral Valve Repair via MitraClip (2023).
  • Contemporary Results of Transcatheter Mitral Valve Procedures (2022).
  • Aortic Valve Calcium Volume Assessment in TAVR Patients (2022).

Research Impact

The available publication record demonstrates continuing engagement in clinically relevant cardiovascular research. Studies addressing procedural optimization, diagnostic imaging, and structural heart interventions provide evidence that may support future improvements in patient care, multidisciplinary practice, and minimally invasive cardiovascular medicine.[4]

Award Suitability

Based on the documented publication record, research metrics, and emphasis on innovative cardiovascular diagnostics and interventions, Mohammad El Garhy’s scholarly activities demonstrate characteristics commonly considered during evaluations for innovation-oriented academic recognition. Award decisions remain dependent upon the official selection criteria established by the organizing committee.[5]

Conclusion

Mohammad El Garhy has contributed to contemporary cardiovascular medicine through investigations involving structural heart disease, catheter-based interventions, and advanced imaging. His research portfolio reflects ongoing participation in clinically significant studies that support evidence generation and innovation within interventional cardiology.

References

  1. Elsevier. Scopus Author Details: Mohammad El Garhy, Author ID 57192109926.
    https://www.scopus.com/authid/detail.uri?authorId=57192109926
  2. El Garhy M. The Role of Endoscopic Ultrasound in Cardiology. Journal of Clinical Medicine (2026). DOI:
    https://doi.org/10.3390/jcm15135006
  3. Open Heart. Impact of Porcelain Aorta on Outcomes in TAVI.
    https://doi.org/10.1136/openhrt-2024-003069
  4. Interventional Cardiology. Transcatheter Mitral Valve Repair via MitraClip.
    https://doi.org/10.15420/icr.2021.28
  5. The Egyptian Heart Journal. Contemporary Results of Transcatheter Mitral Valve Procedures.
    https://doi.org/10.1186/s43044-022-00257-x

Raffaelina Mercogliano | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Raffaelina Mercogliano
Affiliation UniversitĂ  Federico II di Napoli
Country Italy
Scopus ID 24830941800
Documents 52
Citations 1,376 citations by 1,259 documents
h-index 22
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0001-9167-4091

Raffaelina Mercogliano
UniversitĂ  Federico II di Napoli (Italy)

The Innovative Research Award profile recognizes the scholarly achievements and scientific contributions of Raffaelina Mercogliano, a researcher associated with UniversitĂ  Federico II di Napoli, Italy. Her academic portfolio reflects sustained contributions to medicine and health sciences, with a publication record demonstrating interdisciplinary engagement, research visibility, and measurable scientific impact. The recognition is presented within the framework of the International Forensic Scientist Awards and highlights excellence in research productivity, citation influence, and academic leadership.[1][2]

Abstract

This academic recognition profile summarizes the research accomplishments, publication activity, and scholarly influence of Raffaelina Mercogliano. The profile examines research productivity, citation performance, and disciplinary contributions within medicine and health sciences. Available bibliometric indicators suggest a sustained record of scientific engagement and international visibility, supporting consideration for recognition through the Innovative Research Award.[1][3]

Keywords

Innovative Research Award, Raffaelina Mercogliano, Medicine and Health Sciences, Scientific Recognition, Research Excellence, Citation Impact, Academic Achievement, Scholarly Publications, Health Research, International Forensic Scientist Awards.

Introduction

Academic awards play an important role in recognizing the contributions of researchers whose work advances scientific knowledge and professional practice. Evaluation criteria frequently include publication output, citation influence, research quality, and engagement with emerging scientific challenges. Within this context, the profile of Raffaelina Mercogliano reflects a research trajectory characterized by scholarly productivity and measurable impact within medicine and health sciences.[2][4]

Research Profile

Raffaelina Mercogliano is affiliated with UniversitĂ  Federico II di Napoli, one of Italy’s established research institutions. Her scholarly record includes 52 indexed documents and an h-index of 22, reflecting both productivity and sustained citation activity. The available citation metrics indicate broad engagement with her research findings across multiple publications and scientific communities.[1][2]

Research Contributions

The research contributions associated with this profile demonstrate engagement with topics relevant to medicine, health sciences, food safety, public health, and related interdisciplinary domains. Such work contributes to evidence-based practices, scientific understanding, and methodological advancement. The cumulative impact of these contributions is reflected through extensive scholarly citations and continued relevance within the academic literature.[3][5]

Publications

The publication portfolio comprises peer-reviewed scholarly articles indexed within internationally recognized academic databases. These publications contribute to the dissemination of scientific findings and support knowledge exchange among researchers, practitioners, and policy stakeholders. Consistent publication activity demonstrates a commitment to rigorous scientific investigation and scholarly communication.[1]

Research Impact

Research impact can be assessed through citation indicators, publication visibility, and scholarly influence. With 1,376 citations generated across 1,259 citing documents and an h-index of 22, the available metrics indicate meaningful engagement by the scientific community. Such indicators suggest that the research outputs have contributed to ongoing academic discussions and informed subsequent investigations within relevant fields.[1][4]

Award Suitability

Based on documented publication activity, citation performance, institutional affiliation, and demonstrated contributions to medicine and health sciences, Raffaelina Mercogliano presents a profile consistent with the objectives of the Innovative Research Award. The combination of scholarly productivity and measurable research influence supports recognition within international academic award frameworks designed to celebrate excellence and innovation in research.[2]

Conclusion

The scholarly record of Raffaelina Mercogliano reflects sustained academic engagement, recognized research output, and measurable citation influence. Through contributions to medicine and health sciences, the researcher has established a profile characterized by scientific relevance and professional accomplishment. These attributes provide a strong foundation for recognition through the Innovative Research Award and related international research excellence programs.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Raffaelina Mercogliano, Author ID 24830941800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=24830941800
  2. ORCID. (n.d.). ORCID record for Raffaelina Mercogliano.
    https://orcid.org/0000-0001-9167-4091
  3. Mercogliano, R., et al. (2003). Scientific research in food safety and public health. DOI:
  4. Hirsch, J. E. (2005). An index to quantify an individual’s scientific research output. DOI:
    https://doi.org/10.1073/pnas.0507655102
  5. World Health Organization. (n.d.). Health research and evidence-informed policy resources.

Rachael Gakii Murithi | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Rachael Gakii Murithi
Tsinghua University, China

Rachael Gakii Murithi
Affiliation Tsinghua University
Country China
Scopus ID 57221382349
Documents 5
Citations 73
h-index 5
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-6653-3833

The Innovative Research Award recognizes the scholarly contributions of Rachael Gakii Murithi in the interdisciplinary fields of public health, maternal survival studies, environmental exposure analysis, and global health inequality research. Her academic work at Tsinghua University reflects a research-oriented approach focused on evidence-based health analysis, comparative international studies, and systematic reviews addressing vulnerable populations. Her publications contribute to contemporary discourse surrounding maternal mortality, gender inequality, indoor pollution exposure, and health disparities in low- and middle-income countries.[1]

Abstract

Rachael Gakii Murithi has contributed to emerging research discussions within medicine and health sciences through publications examining maternal mortality, environmental pollutants, gender inequality, and adolescent fertility indicators. Her scholarly output integrates quantitative health analysis with comparative global datasets to evaluate structural determinants influencing health outcomes across developing regions.[2]

Keywords

Maternal mortality, global health inequality, adolescent fertility, indoor pollutants, neurodevelopmental disorders, environmental health, public health analytics, comparative health studies.

Introduction

Contemporary health science increasingly emphasizes interdisciplinary methodologies to address inequalities in healthcare access and population health outcomes. Murithi’s work contributes to this framework by examining maternal survival disparities, exposure to airborne pollutants, and sociopolitical determinants of gender inequality across multiple regions.[3] Her studies utilize comparative analyses, systematic review methods, and public health indicators to interpret global health trends.

Research Profile

Murithi’s academic profile includes publications indexed through recognized scholarly databases and citation platforms. Her research interests focus on maternal health, environmental risk assessment, adolescent fertility patterns, and social determinants affecting vulnerable populations. The integration of statistical modeling with comparative international data has enabled her work to address multidimensional public health concerns.[4]

Research Contributions

  • Conducted comparative cluster analyses examining maternal survival inequalities across 49 Sub-Saharan African countries.
  • Investigated adolescent birth rates and female education as determinants of maternal mortality disparities in low- and middle-income countries.
  • Published systematic reviews on indoor pollutants and their association with respiratory, neurodevelopmental, and oncological risks.
  • Explored structural drivers of gender inequality, including fertility patterns and political representation.

Publications

  • Inequality and maternal survival cluster analysis of 49 Sub Saharan countries (2026).
  • Plastic mulching drives microplastic accumulation and redistribution in arid agroecosystems (2026).
  • Adolescent Birth Rates and Female Education Drive Maternal Mortality Disparities in Low- and Middle-Income Countries (2026).

Research Impact

Murithi’s research output has contributed to scholarly discussions surrounding public health inequality and environmental health exposure. Citation metrics indicate academic engagement with her work in areas related to maternal health and environmental risk analysis. Her studies also support policy-oriented discussions concerning education, reproductive health, and pollution-related health outcomes in vulnerable populations.[5]

Award Suitability

The Innovative Research Award acknowledges scholarly contributions demonstrating interdisciplinary relevance, methodological rigor, and measurable academic impact. Murithi’s research portfolio aligns with these criteria through investigations addressing global maternal health disparities, environmental exposure risks, and gender-related public health indicators. Her work reflects ongoing engagement with contemporary healthcare challenges and data-driven research methodologies.[6]

Conclusion

Rachael Gakii Murithi’s academic contributions within medicine and health sciences demonstrate a sustained focus on global health inequality, environmental exposure analysis, and maternal survival research. Through comparative studies, systematic reviews, and interdisciplinary public health investigations, her work contributes to evidence-based understanding of health disparities affecting diverse populations worldwide.

References

  1. Elsevier. (n.d.). Scopus author details: Rachael Gakii Murithi, Author ID 57221382349. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57221382349
  2. Murithi, R. G. (2026). Inequality and maternal survival cluster analysis of 49 Sub Saharan countries. Discover Public Health.
    https://doi.org/10.1186/s12982-026-02069-9
  3. Murithi, R. G. (2026). Adolescent Birth Rates and Female Education Drive Maternal Mortality Disparities in Low- and Middle-Income Countries.
    https://doi.org/10.33140/japm.11.01.01
  4. Murithi, R. G. (2025). Prenatal Exposure to Airborne and Indoor Pollutants and the Risk of Childhood Neurodevelopmental Disorders.
    https://doi.org/10.33140/japm.10.03.02
  5. Murithi, R. G. (2025). Associations between Indoor Pollutants, Neurodevelopmental, Oncological, and Respiratory Health Risks, and Vulnerable Populations: A Systematic Review.
    https://doi.org/10.21203/rs.3.rs-7440867/v1
  6. International Forensic Scientist Awards. (n.d.). Award recognition and academic excellence platform.
    forensicscientist.org

Yury Kustov | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Best Researcher Award

Yury Kustov
Peoples’ Friendship University of Russia
Yury Kustov
Affiliation Peoples’ Friendship University of Russia
Country Russia
Scopus ID 58987836800
Documents 5
Citations 4
h-index 1
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0009-0002-4859-4322

Yury Kustov is a researcher affiliated with the Peoples’ Friendship University of Russia whose scholarly work focuses on medicine, pharmacovigilance, drug safety, pulmonary fibrosis, and clinical pharmacology. His recent publications examine adverse drug reactions, pediatric pharmacotherapy, pulmonary complications, and systematic reviews related to pharmacokinetics and post-COVID-19 outcomes. Through contributions indexed in Scopus, Kustov has participated in interdisciplinary investigations concerning patient safety and evidence-based medical analysis.[1] His profile reflects active engagement in healthcare-related research areas associated with pharmacological monitoring and clinical risk assessment.[2]

Abstract

The academic contributions of Yury Kustov are associated with contemporary clinical medicine and pharmacovigilance research. His published studies explore adverse drug reactions, pulmonary fibrosis, antibiotic safety, and pediatric therapeutic outcomes. Several investigations emphasize spontaneous report database analysis and systematic reviews in order to improve healthcare monitoring and pharmacological safety standards.[3] These contributions support broader scientific discussions regarding medication-related complications and patient-centered clinical evaluation.

Keywords

Pharmacovigilance, Clinical Pharmacology, Pulmonary Fibrosis, Pediatric Medicine, Drug Safety, Post-COVID Research, Pharmacokinetics, Medicine and Health Sciences.

Introduction

The advancement of modern healthcare increasingly depends on pharmacological safety assessment and evidence-based therapeutic monitoring. Researchers involved in pharmacovigilance contribute to the identification of adverse reactions and clinical complications linked to pharmaceutical interventions. Yury Kustov has participated in this research landscape through studies addressing antibacterial drug reactions, pulmonary fibrosis, and pediatric medicine.[4] His publications demonstrate engagement with healthcare datasets and clinical literature reviews that contribute to scientific understanding of treatment-related risks.

Research Profile

Kustov’s academic profile includes journal articles and conference publications indexed through Scopus and related scholarly databases. His research areas include pharmacokinetics in chronic heart failure, pulmonary fibrosis associated with pharmacotherapy, and pediatric antibacterial drug safety. The researcher has also examined Stevens–Johnson syndrome and toxic epidermal necrolysis using spontaneous reporting systems.[5] These studies align with medical efforts to improve treatment evaluation and patient safety methodologies.

Research Contributions

  • Analysis of fluoroquinolone safety in pediatric populations through pharmacovigilance database studies.
  • Systematic review research concerning pharmacokinetic alterations in chronic heart failure patients.
  • Investigations into pulmonary fibrosis and post-COVID-19 pharmacotherapy outcomes.
  • Evaluation of spontaneous adverse drug reaction reports linked to antibacterial medications.

Publications

  • “Safety of fluoroquinolones in pediatric patients: Pharmacovigilance database analysis”
  • “Pharmacokinetic Alterations in Patients with Chronic Heart Failure: A Systematic Review”
  • “Drug-Induced Pulmonary Fibrosis: National Database Analysis”

Research Impact

The research contributions of Yury Kustov demonstrate relevance to healthcare monitoring, medication safety assessment, and evidence-based pharmacology. By utilizing systematic reviews and spontaneous report analyses, his studies contribute to discussions surrounding adverse drug reaction surveillance and therapeutic evaluation. Such research supports clinicians, pharmacologists, and healthcare researchers seeking to understand treatment-related complications in vulnerable patient populations.

Award Suitability

Yury Kustov’s publication record and involvement in pharmacovigilance-related medical studies align with the objectives of the International Forensic Scientist Awards. His focus on drug safety analysis, pulmonary complications, and healthcare risk assessment reflects scholarly engagement with medically significant challenges. The integration of database-driven clinical analysis and systematic review methodologies further demonstrates research activity associated with modern healthcare science and patient protection initiatives.

Conclusion

Yury Kustov has contributed to medicine and health sciences through publications examining pharmacovigilance, pulmonary fibrosis, clinical pharmacology, and pediatric drug safety. His academic profile reflects ongoing participation in evidence-based medical research and healthcare monitoring studies. Through indexed scholarly outputs and DOI-linked publications, his work contributes to the broader scientific understanding of pharmaceutical safety and patient-centered clinical investigation.

References

  1. Elsevier. (n.d.). Scopus author details: Yury Kustov, Author ID 58987836800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58987836800
  2. ORCID. (n.d.). Yury Kustov ORCID profile.
    https://orcid.org/0009-0002-4859-4322
  3. Kustov, Y. (2026). Safety of fluoroquinolones in pediatric patients: Pharmacovigilance database analysis.
    https://doi.org/10.1177/09246479251398995
  4. Kustov, Y. (2025). Pharmacokinetic Alterations in Patients with Chronic Heart Failure: A Systematic Review.
    https://doi.org/10.3390/ijms26199495
  5. Kustov, Y. (2024). Drug-Induced Pulmonary Fibrosis: National Database Analysis.
    https://doi.org/10.3390/biomedicines12122650

Hong Zhang | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Hong Zhang
University of Texas Southwestern Medical Center, United States
Hong Zhang
Affiliation University of Texas Southwestern Medical Center
Country United States
Scopus ID 57192482890
Documents 28
Citations 550
h-index 13
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0003-3056-0343

Hong Zhang, is an orthopedic surgeon, biomedical innovator, and musculoskeletal research specialist affiliated with the University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children in Dallas, Texas. His research activities focus primarily on pediatric spinal deformities, growth modulation, spinal instrumentation development, scoliosis correction technologies, and minimally invasive spinal surgery. Through a combination of clinical orthopedic expertise and translational biomedical engineering, Zhang has contributed to the development of novel surgical systems and patented technologies intended to improve the treatment of severe spinal deformities and early-onset scoliosis.[1]

As Director of the Division of Creative Innovations within the Seay Center for Musculoskeletal Research, Zhang has overseen multidisciplinary investigations involving experimental spine biomechanics, orthopedic implant design, pediatric spine growth modulation, and surgical correction strategies. His publication record, citation metrics, and patent portfolio demonstrate sustained scholarly engagement in orthopedic research and spinal deformity innovation.[2]

Abstract

Hong Zhang is recognized for contributions to orthopedic surgery research, spinal deformity correction technologies, and pediatric musculoskeletal innovation. His work has focused on improving surgical outcomes for severe scoliosis and kyphosis through biomechanical research, implant design, and translational clinical investigations. Zhang has also contributed to orthopedic device development through multiple United States patents related to spinal correction systems and stabilization technologies.[3] His scholarly publications in journals such as Spine Deformity, European Spine Journal, and Seminars in Spine Surgery highlight continued engagement in experimental spine research and orthopedic innovation.[4]

Keywords

Orthopedic Surgery, Pediatric Scoliosis, Spinal Deformity, Spine Research, Musculoskeletal Innovation, Early-Onset Scoliosis, Orthopedic Instrumentation, Growth Modulation, Biomedical Engineering, Pediatric Orthopedics

Introduction

The field of pediatric spinal deformity research requires coordinated advances in biomechanics, surgical techniques, implant engineering, and long-term clinical evaluation. Hong Zhang has contributed to this interdisciplinary area through research addressing early-onset scoliosis, thoracic deformities, vertebral correction systems, and growth-preserving spinal interventions. His investigations combine experimental orthopedic science with clinically applicable instrumentation design.[5]

Zhang obtained his medical degree from Tianjin Medical University in China and completed orthopedic surgery training at Tianjin Hospital before undertaking international orthopedic research and clinical scholarship programs in Italy and the United States. Since joining the University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children, he has participated in numerous collaborative orthopedic research initiatives focused on pediatric spine disorders and surgical innovation.[6]

Research Profile

Hong Zhang currently serves as Director of the Division of Creative Innovations within the Center of Excellence in Spine Research at the Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, Texas. He also holds the academic position of Associate Professor in the Department of Orthopaedic Surgery at the University of Texas Southwestern Medical Center.[1]

His research profile demonstrates sustained focus on pediatric spinal deformities, including early-onset scoliosis, thoracic kyphosis, spinal growth modulation systems, minimally invasive thoracoscopic procedures, and spinal instrumentation biomechanics. Zhang’s work frequently integrates engineering methodologies, experimental spine models, and translational orthopedic device development.[7]

  • Early-onset scoliosis and pediatric spine growth research
  • Orthopedic implant and spinal instrumentation development
  • Growth modulation systems for spinal correction
  • Biomechanical evaluation of spinal deformity devices
  • Experimental and translational musculoskeletal research
  • Minimally invasive spinal surgical technologies

Research Contributions

Zhang has contributed extensively to the development of innovative spinal correction systems intended for severe spinal deformities and pediatric scoliosis treatment. His patented orthopedic technologies include spinal rod reduction devices, pedicle screw systems, stabilization fasteners, and hinge-link spinal correction devices designed to improve alignment control and surgical correction efficiency.[8]

A significant component of his recent research involves the development of growth modulation systems using dynamic spinal correction approaches. Experimental investigations involving porcine models and three-dimensional simulation technologies have supported the evaluation of biomechanical effectiveness and safety profiles of novel correction systems.[9]

Zhang’s work on vertebral column resection systems and angular kyphosis reduction devices has also contributed to understanding correction strategies for severe thoracic spinal deformities. These studies have explored both implant mechanics and surgical feasibility in complex deformity correction procedures.[10]

  • Development of hinge-link spinal correction technologies
  • Novel uniplanar correction systems for angular kyphosis
  • Dynamic scoliosis correction and growth modulation research
  • Biomechanical studies of pediatric spinal instrumentation
  • Experimental orthopedic implant design and testing

Publications

Hong Zhang has authored and co-authored multiple peer-reviewed scientific publications addressing pediatric scoliosis, thoracic deformity correction, spine biomechanics, and orthopedic surgical technologies.[11]

  1. Zhang H, Lima JM, Jo CH, and Sucato DJ. The closing triradiate cartilage stage identifies accelerated curve progression in idiopathic scoliosis. Spine Deformity (2026).
  2. Zhang H, Ross D, and Sucato DJ. Evaluation of a novel angular kyphosis reduction device for vertebral column resection in severe angular kyphosis. European Journal of Orthopaedic Surgery & Traumatology (2026).
  3. Zhang H, Ross D, and Sucato DJ. A new uniplanar correction strategy for severe thoracic kyphosis: concept, device design, and simulation with a 3D-printed model. Spine Deformity (2026).
  4. Zhang H, Niese B, and Sucato DJ. Growth modulation and dynamic correction of early-onset thoracic scoliosis using a PEEK spring rib plate system: a porcine model study. Spine Deformity (2026).
  5. Brooks JT, Carron CJ, Zhang H, and Sucato DJ. Going anterior for the surgical management of pediatric scoliosis: Indications and technique pearls. Seminars in Spine Surgery (2025).

Research Impact

According to available Scopus metrics, Zhang has produced 28 indexed scholarly documents with approximately 550 citations and an h-index of 13, reflecting measurable academic influence within orthopedic surgery and musculoskeletal research communities.[1] His research output has contributed to the scientific understanding of pediatric spinal deformities, spinal growth dynamics, and orthopedic implant biomechanics.

His work has also received recognition through national and international awards, including the John H. Moe Award for Best Basic Science presented by the Scoliosis Research Society in both 2009 and 2010.[12] Additional grant support from organizations such as the Pediatric Orthopedic Society of North America and the Scoliosis Research Society further reflects the relevance of his investigations within pediatric orthopedic research.

Award Suitability

Hong Zhang’s academic profile aligns with the objectives of the Innovative Research Award due to his sustained contributions to orthopedic surgery innovation, spinal deformity correction technologies, and translational pediatric spine research. His work demonstrates interdisciplinary integration between clinical orthopedic practice, biomechanical engineering, and experimental medical device development.[8]

The combination of peer-reviewed publications, patented surgical systems, funded research projects, and international scientific recognition supports consideration of Zhang’s contributions within the field of medicine and health sciences. His focus on improving treatment strategies for complex pediatric spinal conditions reflects ongoing commitment to clinically relevant biomedical innovation.[10]

Conclusion

Hong Zhang has established a scholarly and clinical research profile centered on pediatric orthopedic innovation and spinal deformity correction. Through collaborative orthopedic research, patented instrumentation systems, and translational experimental studies, he has contributed to the advancement of spinal surgery technologies and pediatric musculoskeletal care. His publication history, research awards, and scientific contributions collectively support recognition within international academic and biomedical innovation platforms.[11]

References

  1. Elsevier. (n.d.). Scopus author details: Hong Zhang, Author ID 57192482890. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57192482890
  2. University of Texas Southwestern Medical Center. (n.d.). Faculty and research profile information for Hong Zhang.
  3. United States Patent and Trademark Office. (2010). Method for the Correction of Spinal Deformities Using Rod-Plate Anterior System.
  4. Springer Nature. (2026). Spine Deformity journal publications authored by Hong Zhang.
  5. Zhang H, Ross D, and Sucato DJ. (2026). Evaluation of a novel angular kyphosis reduction device for vertebral column resection in severe angular kyphosis.
    https://doi.org/10.1007/s00590-026-04778-y
  6. Texas Scottish Rite Hospital for Children. (n.d.). Seay Center for Musculoskeletal Research profile.
  7. Zhang H, Niese B, and Sucato DJ. (2026). Growth modulation and dynamic correction of early-onset thoracic scoliosis using a PEEK spring rib plate system.
    https://doi.org/10.1007/s43390-026-01284-3
  8. United States Patent and Trademark Office. (2023). Hinge-Link Spinal Correction Device and Method.
  9. Wang XB, Zhang H, and Sucato DJ. (2023). Unilateral thoracic spinal nerve resection creates early onset thoracic scoliosis in an immature porcine model.
    https://doi.org/10.1007/s00586-023-07804-3
  10. Zhang H, Ross D, and Sucato DJ. (2024). A Novel Uniplanar Clamp-Hinge Correction System for Vertebral Column Resection of Severe Angular Kyphosis.
    https://doi.org/10.1007/s43390-023-00770-2
  11. Elsevier. (n.d.). Publication and citation metrics for Hong Zhang in orthopedic research.
  12. Scoliosis Research Society. (2010). John H. Moe Award for Best Basic Science.

Ebeney Whillas | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Ms. Ebeney Whillas | Medicine and Health Sciences | Research Excellence Award

University of Wollongong | Australia

Ms. Ebeney Whillas is a sports nutrition researcher whose work focuses on nutrition-related experiences during the transition from elite sport to post-competitive life. Her research is grounded in qualitative inquiry, addressing a critical gap in sports nutrition literature by centering the voices of former elite athletes. She is the lead author of a peer-reviewed article published in Nutrients (MDPI), which examines how entrenched sporting cultures continue to shape eating behaviours, health perceptions, and wellbeing after retirement from elite competition. Her scholarship contributes to a growing recognition that athlete nutrition support must extend beyond performance-focused phases to encompass long-term health and adjustment. Ms. Whillas’ research interests include athlete transition, sports nutrition culture, and the relationship between nutrition practices and mental wellbeing. Through her work, she provides evidence to inform more holistic, sustainable, and athlete-centered nutrition interventions across the full athletic lifespan.

Profiles: Sci Profiles | LinkedIn

Featured Publications

‱ Whillas, E. K., Craddock, J. C., & Lambert, K. (2025). Navigating nutrition beyond elite sport: A qualitative exploration of experiences after retirement. Nutrients, 17(24), Article 3920. https://doi.org/10.3390/nu17243920

Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Published on by Forensic Scientist Awards

Assoc. Prof. Dr. Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Izmir Katip Çelebi University AtatĂŒrk Training and Research Hospital | Turkey

Dr. Tuncay KırÄ±ĆŸ, an Associate Professor at Ä°zmir KĂątip Çelebi University, Izmir, Turkey, is a distinguished cardiology researcher recognized for his extensive contributions to cardiovascular medicine, particularly in the fields of cardiovascular risk prediction, interventional cardiology, acute coronary syndromes, and cardiac biomarkers. His research has provided valuable insights into myocardial infarction, pulmonary embolism, renal complications following cardiac interventions, and the prognostic implications of biochemical and hematological markers in predicting patient outcomes. Dr. Tuncay KırÄ±ĆŸ has authored 83 peer-reviewed publications in prestigious international journals indexed in SCI and SCI-Expanded, including Angiology, BMC Cardiovascular Disorders, The Anatolian Journal of Cardiology, Clinical and Experimental Hypertension, Herz, and Acta Radiologica. His works have received 591 citations from 544 documents, with an h-index of 15, according to Scopus (Author ID: 55321350600), reflecting his strong academic impact. His studies emphasize innovative predictive and prognostic modeling approaches, such as exploring the fibrinogen-to-albumin ratio, red cell distribution width, and lymphocyte-to-monocyte ratio as novel indicators of adverse cardiovascular events and renal complications. Beyond his research, he has supervised postgraduate theses on cardiovascular risk assessment, contributed to collaborative projects in clinical and translational cardiology, and serves as Editor of the Ege Klinikleri Tıp Dergisi. As an active reviewer for several international cardiology journals, Dr. Tuncay KırÄ±ĆŸ continues to advance evidence-based cardiology through data-driven research, bridging clinical practice with innovation to improve patient outcomes and global cardiovascular health.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  • Yildirim, S. E., Yildirim, T., KırÄ±ĆŸ, T., & Avci, E. (2025, October). Prognostic value of the NAPLES score and serum uric acid in chronic coronary syndrome: Evidence from time-dependent ROC and time-varying hazard ratio analyses. Journal of Clinical Medicine, 14(20), 7416. https://doi.org/10.3390/jcm14207416

  • Tiryaki, M. M., Yılmaz, C., Ince, H. S., Karaca, B., Kayaalti Esin, F., & KırÄ±ĆŸ, T. (2025, September). Neutrophil percentage-to-albumin ratio as a predictor of in-hospital mortality in infective endocarditis. Biomarkers in Medicine, 19(17), 1–8. https://doi.org/10.1080/17520363.2025.2562554

  • Akkan, G., KırÄ±ĆŸ, T., Esin, F., & Karaca, M. (2025, May). Evaluation of mortality and hospitalization due to decompensated heart failure and appropriate shocks in reduced ejection fraction in patients with an implantable cardioverter–defibrillator according to a novel tissue Doppler echocardiographic method. Journal of Clinical Medicine, 14(9), 3226. https://doi.org/10.3390/jcm14093226

  • Esin, F., Bozkurt, H., Palac, B., Akar, B., KırÄ±ĆŸ, T., Özdemir, E., & Karaca, M. (2025, February). The impact of pleural effusion on long-term mortality in patients undergoing transcatheter aortic valve implantation. Journal of Clinical Medicine, 14(5), 1596. https://doi.org/10.3390/jcm14051596

  • Usta, A., Sancakli Usta, C., Lafci, D., KırÄ±ĆŸ, T., & Avci, E. (2024, December). Contrast induced nephropathy in women with infertility undergoing hysterosalpingography. Reproductive Biology and Endocrinology, 22(1). https://doi.org/10.1186/s12958-024-01334-3

Kyaw Thein | Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Assist. Prof. Dr. Kyaw Thein | Health Sciences | Best Researcher Award

MD | Comprehensive Cancer Centers of Nevada – Central Valley | United States

Dr. Kyaw Zin Thein, MD, is a highly skilled Medical Oncologist and Hematologist currently practicing at the Central Valley Treatment Center – Twain, affiliated with the Comprehensive Cancer Centers of Nevada. He also serves as a Clinical Assistant Professor at Touro University Nevada (TUN) and the University of Nevada, Las Vegas (UNLV). His dedication to patient care, research, and education has solidified his reputation as a leader in precision oncology and hematology.

Profile

Scopus

Google scholar

Orcid

Strengths for the Awards

  • Impressive Academic and Clinical Training
    • Dr. Kyaw Zin Thein has a robust academic background, including advanced fellowships in hematology, oncology, and investigational cancer therapeutics at world-renowned institutions such as MD Anderson Cancer Center.
    • A double board-certified oncologist and hematologist with certifications valid through 2029, showcasing his extensive expertise and commitment to maintaining professional standards.
  • Research Contributions and Publications
    • Author of 53 peer-reviewed journal articles, demonstrating significant contributions to advancing knowledge in oncology and hematology.
    • Published book chapters on cutting-edge topics like poly (ADP-ribose) polymerase inhibitors and multidisciplinary paradigms for head and neck cancer, reflecting his thought leadership in the field.
  • Teaching and Mentorship
    • Active roles as Clinical Assistant Professor at UNLV and Touro University Nevada, contributing to medical education.
    • Mentorship of numerous trainees, ranging from medical students to fellows, highlighting his commitment to shaping the next generation of oncologists and researchers.
  • Leadership and Awards
    • Held leadership roles, including Chief Fellow, Chief Resident, and committee member positions at esteemed institutions.
    • Recipient of multiple awards, such as the ASH Abstract Achievement Award and Research Recognition Awards, underscoring his excellence in research and clinical practice.

Education 🎓

Dr. Thein completed his M.B., B.S. (Doctor of Medicine) at the Institute of Medicine 1, Yangon, Myanmar (2004–2010). His advanced training includes:

  • Residency in Internal Medicine at Kingsbrook Jewish Medical Center, NY (2012–2015).
  • Fellowship in Hematology & Medical Oncology at Texas Tech University Health Sciences Center, TX (2016–2019).
  • Advanced Fellowships in Investigational Cancer Therapeutics and Oncologic Emergency Medicine at the University of Texas MD Anderson Cancer Center (2015–2020).

Professional Experience đŸ’Œ

Dr. Thein has held numerous prestigious positions:

  • Medical Oncologist/Hematologist, Central Valley Treatment Center, Nevada (2023–present).
  • Assistant Professor of Medicine, Division of Hematology and Medical Oncology, Oregon Health & Science University (OHSU) (2020–2023).
  • Chief Fellow, Texas Tech University Health Sciences Center (2018–2019).
  • Member of multiple professional committees, including the Knight Cancer Institute’s Data and Safety Monitoring Committee.

Research Interests On Health Sciences🔬

Dr. Thein’s research focuses on precision oncology, investigational cancer therapeutics, and immunotherapy. He has contributed extensively to advancing cancer care through his work on targeted therapies, combination regimens, and innovative diagnostic methods.

Awards & Recognitions 🏆

Dr. Thein has received numerous accolades, including:

  • ASH Abstract Achievement Award, American Society of Hematology (2016).
  • Research Recognition Awards from Kingsbrook Jewish Medical Center (2014, 2015).
  • Excellence in Education Award, Myanmar American Medical Education Society (2011).

Publications 📚

  • Copper deficiency anemia
    • Authors: ZW Myint, TH Oo, KZ Thein, AM Tun, H Saeed
    • Year: 2018
    • Citations: 298
  • 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
    • Authors: G Han, G Yang, D Hao, Y Lu, K Thein, BS Simpson, J Chen, R Sun, et al.
    • Year: 2021
    • Citations: 136
  • Precision therapy for RET-altered cancers with RET inhibitors
    • Authors: KZ Thein, V Velcheti, BHM Mooers, J Wu, V Subbiah
    • Year: 2021
    • Citations: 112
  • Adverse effects of immune checkpoint therapy in cancer patients visiting the emergency department of a comprehensive cancer center
    • Authors: I El Majzoub, A Qdaisat, KZ Thein, MA Win, MM Han, K Jacobson, et al.
    • Year: 2019
    • Citations: 91
  • Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism
    • Authors: MA Win, KZ Thein, A Qdaisat, SCJ Yeung
    • Year: 2017
    • Citations: 83
  • The contemporary management of cancers of the sinonasal tract in adults
    • Authors: R Thawani, MS Kim, A Arastu, Z Feng, MT West, NF Taflin, KZ Thein, R Li, et al.
    • Year: 2023
    • Citations: 74
  • Clinical and Molecular Characterization of POLE Mutations as Predictive Biomarkers of Response to Immune Checkpoint Inhibitors in Advanced Cancers
    • Authors: B Garmezy, J Gheeya, HY Lin, Y Huang, T Kim, X Jiang, KZ Thein, et al.
    • Year: 2022
    • Citations: 74
  • Therapeutics targeting mutant KRAS
    • Authors: KZ Thein, AB Biter, DS Hong
    • Year: 2021
    • Citations: 55
  • Pernicious anemia: Pathophysiology and diagnostic difficulties
    • Authors: TW Htut, KZ Thein, TH Oo
    • Year: 2021
    • Citations: 52
  • Venous thromboembolism risk in patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with combined CDK 4/6 inhibitors plus endocrine therapy
    • Authors: KZ Thein, TW Htut, S Ball, S Swarup, A Sultan, TH Oo
    • Year: 2020
    • Citations: 45

Conclusion 🌟

Dr. Kyaw Zin Thein is a visionary leader in oncology and hematology, with a career distinguished by cutting-edge research, impactful teaching, and exceptional clinical care. His dedication to advancing cancer therapies and mentoring future medical professionals underscores his commitment to transforming cancer treatment and education worldwide.

Silvia Di Bonaventura | Health Sciences | Young Scientist Award

Published on by Forensic Scientist Awards

Ms. Silvia Di Bonaventura | Health Sciences | Young Scientist Award

Lecturer-Researcher | Rey Juan Carlos University | Spain

Silvia Di Bonaventura is a passionate researcher, professor, and social entrepreneur with a commitment to advancing scientific innovation. Her journey reflects an insatiable curiosity, strong leadership, and dedication to contributing to transformative projects in health and biomedicine. Fluent in five languages, she combines global perspectives with academic rigor and entrepreneurial vision to address complex challenges in research and healthcare.

Profile:

Strengths for the Awards:

  1. Academic Excellence:
    Silvia’s strong academic foundation includes degrees in Physiotherapy, Invasive Physiotherapy, and an ongoing PhD in Pain Research, coupled with a Master’s in Clinical Research at Harvard University, showcasing her commitment to scientific rigor and innovation.
  2. Research Contributions:
    Silvia has demonstrated significant contributions to pain research, with notable publications on neuromodulation and digital health interventions for chronic pain. Her work combines clinical relevance and innovative methodologies, emphasizing her potential to make lasting impacts in biomedicine.
  3. Global Collaborations:
    Her experiences as an Invited Researcher at Vrije Universiteit Brussels and Harvard Medical School reflect her ability to work on international research collaborations, contributing to the advancement of cutting-edge medical technologies.
  4. Entrepreneurial Leadership:
    As the CEO of Bei (a digital health app for fibromyalgia) and the Founder of PainCorp, Silvia has effectively bridged research with practical healthcare solutions, emphasizing her visionary approach and ability to create real-world impact.
  5. Awards and Recognitions:
    Silvia’s accolades, including the Banco Santander Scholarship, Young Emerging Leader 2022, and the Outstanding Leadership Award, highlight her dedication, leadership, and exceptional achievements in the field.
  6. Multilingual Communication Skills:
    Fluent in five languages, Silvia has the ability to collaborate and communicate effectively across diverse cultures, enhancing her research’s global reach and impact.

🎓Education 

  • Diploma in Computer Science (2009–2014)
    Instituto TĂ©cnico Industrial “IIS” – TE
  • Degree in Physiotherapy (2014–2018)
    Universidad Alfonso X El Sabio
  • Master’s Degree in Invasive Physiotherapy (2017–2018)
    Universidad Camilo José Cela
  • Master’s Degree in Clinical Research (2024–2024)
    Harvard University
  • PhD in Pain Research (2021–Present)
    Universidad Rey Juan Carlos

đŸ’ŒExperience 

  • Physiotherapist & Co-Director
    Clínica Gatzambide (2018–2022)
    Led a successful physiotherapy practice focused on personalized patient care.
  • Professor & Researcher
    Rey Juan Carlos University (2021–Present)
    Teaching and conducting groundbreaking research in pain management.
  • Invited Researcher
    Vrije Universiteit Brussels (2023) & Harvard Medical School (2024)
    Advanced research on neuromodulation and pain mechanisms.
  • Entrepreneurial Roles
    • CEO & Founder of Bei (2024–Present): Innovating solutions for fibromyalgia self-management.
    • President of PainCorp (2024–Present): Dedicated to pain research and treatment.
    • Research Fellow at Mit LinQ and Harvard (2024–Present): Driving forward collaborative research initiatives.

🔬Research Interests On Health Sciences

Silvia’s research centers on pain management, clinical research, neuromodulation, and digital health solutions. She is particularly focused on designing innovative interventions for chronic pain conditions such as fibromyalgia, combining scientific rigor with practical applications for patient care.

🏆Awards 

  • Top 15 Graduates in Spain (Physiotherapy Ranking)
  • Banco Santander Scholarship (Best Academic Record)
  • PI in Competitive Funding (Biomedicine Research)
  • Entrepreneurship Babson College Scholarship
  • Nova Talent Member
  • Young Emerging Leader ’22 (Korea World Summit)
  • Outstanding Leadership Award (Harbour Space University)

đŸ„‡Achievements & Certifications

  • Recognized as one of the Top 15 Graduates in Spain in Physiotherapy.
  • Awarded Banco Santander Scholarship for academic excellence.
  • Recipient of Babson College Entrepreneurship Scholarship for advancing digital health solutions.
  • Certified in Italian (Native), Spanish (C2), English (C1), French (B1), and Chinese (HSK2).

🌍Final Note

Silvia Di Bonaventura exemplifies a modern researcher blending academic excellence, global collaboration, and entrepreneurship. Through her multifaceted roles, she seeks to bridge the gap between research and real-world impact, paving the way for transformative solutions in healthcare.

Publication Top Note’s

“How Does Conditioned Pain Modulation Influence Motor Imagery Processes in Women with Fibromyalgia Syndrome? A Cross-Sectional Study Secondary Analysis”

  • Authors: VĂ­ctor Riquelme-Aguado, Silvia Di-Bonaventura, MarĂ­a Elena GonzĂĄlez-Álvarez, Alazne Zabarte-Del Campo, JosuĂ© FernĂĄndez-Carnero, Antonio Gil-Crujera, Francisco GĂłmez-Esquer, Jorge Hugo Villafañe
  • Journal: Journal of Clinical Medicine
  • Year: 2024

“The Link between Endogenous Pain Modulation Changes and Clinical Improvement in Fibromyalgia Syndrome: A Meta-Regression Analysis”

  • Authors: Kevin Pacheco-Barrios, Rafaela Machado Filardi, Luis Fernando GonzĂĄlez-GonzĂĄlez, Nayeon Park, Fernanda Queiroz Petrus, Alba Navarro-Flores, Silvia Di-Bonaventura, Luana Gola Alves, Fernanda Queiroz, Felipe Fregni
  • Journal: Biomedicines
  • Year: 2024

“Perceived Benefits and Limitations of a Psychoeducation Program for Patients with Fibromyalgia: An Interpretative Phenomenological Analysis”

  • Authors: Silvia Di-Bonaventura, RaĂșl Ferrer-Peña, JoaquĂ­n Pardo-Montero, JosuĂ© FernĂĄndez-Carnero, Roy La Touche
  • Journal: Frontiers in Psychology
  • Year: 2024

“Effectiveness of Biobehavioral Therapeutic Education in Chronic Low Back Pain Intensity and Disability: A Systematic Review”

  • Authors: David RuĂ­z-del RĂ­o, Roy La Touche, Gwendoline Giolito, Silvia Di-Bonaventura, MĂłnica Grande-Alonso, Álvaro Reina Varona
  • Journal: Journal of MOVE and Therapeutic Science
  • Year: 2024

“Can a Specific Biobehavioral-Based Therapeutic Education Program Lead to Changes in Pain Perception and Brain Plasticity Biomarkers in Chronic Pain Patients? A Study Protocol for a Randomized Clinical Trial”

  • Authors: Silvia Di Bonaventura, Stephen D. Ginsberg, JosuĂ© FernĂĄndez Carnero, RaĂșl Ferrer-Peña
  • Journal: PLOS ONE
  • Year: 2024

“Effect of Different Physical Therapy Interventions on Brain-Derived Neurotrophic Factor Levels in Chronic Musculoskeletal Pain Patients: A Systematic Review”

  • Authors: Silvia Di-Bonaventura, JosuĂ© FernĂĄndez-Carnero, Luis Matesanz-GarcĂ­a, Alberto Arribas-Romano, Andrea Polli, RaĂșl Ferrer-Peña
  • Journal: Life
  • Year: 2023